Home› Europe› EEA Joint Committee› Decision of the EEA Joint Committee No 16/2024 of 2 February...
Date: 27-Jun-2024 Category: Not Applicable State: Union Government Country: Europe

Decision of the EEA Joint Committee No 16/2024 of 2 February 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1553]

Issued by EEA Joint Committee · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Key Changes

  • A new point 13zzzzzzzzzzzzzk is inserted after point 13zzzzzzzzzzzzzj to include '32023 R 0515: Commission Implementing Regulation (EU) 2023/515 of 8 March 2023 renewing the approval of the active substance abamectin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 71, 9.3.2023, p. 22).'
  • The text of Implementing Regulation (EU) 2023/515 in Icelandic and Norwegian languages will be published in the EEA Supplement to the Official Journal of the European Union and will be authentic.
  • The decision entered into force on 3 February 2024, provided that all notifications under Article 103(1) of the EEA Agreement have been made.
  • Annex II to the EEA Agreement, Chapter XV, is amended to include Commission Implementing Regulation (EU) 2023/515.
  • Point 13a of Annex II is updated to include '32023 R 0515: Commission Implementing Regulation (EU) 2023/515 of 8 March 2023 (OJ L 71, 9.3.2023, p. 22).'

What it means

  • The Decision of the EEA Joint Committee No 16/2024 amends Annex II to the EEA Agreement to incorporate Commission Implementing Regulation (EU) 2023/515, which renews the approval of the active substance abamectin.

Impact Analysis

Businesses involved in pesticides

  • Action Item: Review current practices related to abamectin and ensure alignment with the requirements of Regulation (EU) 2023/515.

Agricultural Sector

  • Action Item: Stay informed about any updated guidelines or restrictions on the use of abamectin and adjust agricultural practices accordingly.

EEA Member States

  • Action Item: National authorities should update their regulatory frameworks to reflect the incorporation of Commission Implementing Regulation (EU) 2023/515.

Consumers

  • Action Item: No direct action required, but consumers can stay informed about pesticide regulations and their impact on food production.

Key Entities Referenced

EEA Joint Committee: The decision-making body responsible for amending the EEA Agreement. Commission Implementing Regulation (EU) 2023/515: Regulation renewing the approval of the active substance abamectin. Regulation (EC) No 1107/2009: Regulation of the European Parliament and of the Council concerning the placing of plant protection products on the market. Commission Implementing Regulation (EU) No 540/2011: Regulation implementing Regulation (EC) No 1107/2009 as regards the list of approved active substances. EEA Agreement: Agreement on the European Economic Area.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2024/1553 27.6.2024 DECISION OF THE EEA JOINT COMMITTEE No 16/2024 of 2 February 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1553] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof, Whereas: (1) Commission Implementing Regulation (EU) 2023/515 of 8 March 2023renewing the approval of the active substance abamectin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011(1)is to be incorporated into the EEA Agreement. (2) Annex II to the EEA Agreement should therefore be amended accordingly, HAS ADOPTED THIS DECISION: Article 1 Chapter XV of Annex II to the EEA Agreement shall be amended as follows: 1. The following indent is added in point 13a (Commission Implementing Regulation (EU) No 540/2011): ‘— 32023 R 0515: Commission Implementing Regulation (EU) 2023/515 of 8 March 2023 (OJ L 71, 9.3.2023, p. 22).’ 2. The following point is inserted after point 13zzzzzzzzzzzzzj (Commission Implementing Regulation (EU) 2023/216): ‘13zzzzzzzzzzzzzk. 32023 R 0515: Commission Implementing Regulation (EU) 2023/515 of 8 March 2023 renewing the approval of the active substance abamectin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 71, 9.3.2023, p. 22).’ Article 2 The text of Implementing Regulation (EU) 2023/515 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic. Article 3 This Decision shall enter into force on 3 February 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made(*). Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Done at Brussels, 2 February 2024. For the EEA Joint Committee The President Nicolas VON LINGEN (1) OJ L 71, 9.3.2023, p. 22. (*) No constitutional requirements indicated. ELI: http://data.europa.eu/eli/dec/2024/1553/oj 1/1

Continue your research

Related Documents from EEA Joint Committee